Campylobacter: The new leader in food-borne disease aetiology

Reviews and Research in Medical Microbiology

Volumn 12, Issue 4, 2001, Pages 187-198

  Rollins, David M ^a   Joseph, Sam W ^a  

^a Bldg 142   (United States)

Author keywords

Campylobacter; Diarrhoea; Epidemiology; Food borne; Gastroenteritis; Toxins

Indexed keywords

MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIGEN RECOGNITION; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; CAMPYLOBACTER; DIARRHEA; FOOD POISONING; GASTROENTERITIS; GRAM NEGATIVE INFECTION; HUMAN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CAMPYLOBACTER;

EID: 0035204650     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200110000-00001     Document Type: Review

References (75)

1. Experimental Campylobacter jejuni infection in humans
2. Infective dose of Campylobacter jejuni in milk
3. Campylobacters associated with human diarrhoeal disease
4. Epidemiologic and clinical features of Campylobacter jejuni infections
5. Reactive arthritis associated with Campylobacter jejuni enteritis
6. Campylobacter bacteraemia in England and Wales, 1981-91
7. Experimental Campylobacter jejuni infection of adult mice
8. Related Vibrio in stools
9. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: Emendation of generic descriptions and proposal of Arcobacter gen. nov
10. Proposal of minimal standards for describing new species of the family Campylobacteriaceae
11. Identification methods for campylobacters, helicobacters, and related organisms
12. Proposal for a new family, Campylobacteriaceae
13. Genus Campylobacter
14. Survival of Campylobacter fetus subsp, jejuni in biological milieus
15. Viable but nonculturable stage of Campylobacter jejuni and its role in survival in the natural aquatic environment
16. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations
17. Campylobacter infections in developing countries
18. Campylobacter jejuni
19. A demographic survey of Campylobacter Salmonella, and Shigella infections in England
20. Identification, purification, and characterization of major antigenic proteins of Campylobacter jejuni
21. Primary structure analysis and adhesion studies on the major outer membrane protein of Campylobacter jejuni
22. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection
23. Campylobacter jejuni outer membrane proteins are antigenic for humans
24. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens
25. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors
26. Analysis of the role of flagella in the heat-labile Lior serotyping scheme of thermophilic campylobacters by mutant allele exchange
27. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease
28. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States
29. The immune system response to Campylobacter infection
30. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age
31. Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand
32. Pathogenesis of Campylobacter fetus infections: Critical role of high molecular weight S-layer proteins in virulence
33. Pathophysiology of Campylobacter enteritis
34. Campylobacter species and Guillain-Barre syndrome
35. Guillain-Barre syndrome and Fisher's syndrome following Campylobacter jejuni infection
36. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: Implications for pathogenesis
37. Clinical and epidemioogical features of non-jejuni, non-coli Campylobacter species
38. Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells
39. Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates
40. An environmentally regulated pilus-like appendage involved in Campylobacter pathogenesis
41. Adhesion to HeLa Cells of Campylobacter jejuni and C. coli outer membrane components
42. Effect of enteroviruses on adherence to and invasion of Hep-2 cells by Campylobacter isolates
43. Cellular events and intracellular survival of Campylobacter jejuni during infection of Hep-2 cells
44. Effect of mucin on Campylobacter jejuni association and invasion on Hep-2 cells
45. Altered synthetic response of Campylobacter jejuni to co-cultivation with human epithelial cells is associated with enhanced internalization
46. Factors that influence the interaction of Campylobacter jejuni with cultured mammalian cells
47. Adhesion to and invasion of HEp-2 cells by Campylobacter spp
48. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii
49. Iron acquisition in microbial pathogenesis
50. Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coll
51. Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its product
52. Campylobacter jejuni -induced signal transduction in host intestinal epithelial cells
53. Translocation of Campylobacter jejuni across human polarized epithelial cell monolayer cultures
54. Campylobacter jejuni associates with microtubules and dynein during invasion into human intestinal cells
55. Selective association and transport of Campylobacter jejuni through M cells of rabbit Peyer's patches
56. Characteristics of the internalization and intracellular survival of Campylobacter fejuni in human epithelial cell cultures
57. Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli
58. Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhoea and from healthy laying hens
59. Demonstration of cholera-like enterotoxin by C. jejuni
60. Toxins produced by Campylobacter jejuni and Campylobacter coli
61. Genetic probing of Campylobacter jejuni for cholera toxin and E. coli heat-labile enterotoxin
62. Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the U.S.A
63. Detection of hemolytic activity of Campylobacters by agarose hemolysis and microplate assay
64. Iron acquisition and hemolysin production by Campylobacter jejuni
65. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp
66. Hepatotoxic activity of Campylobacter jejuni
67. Demonstration of a cytotoxin from Campylobacter jejuni
68. In vivo and in vitro studies of a cytotoxin from Campylobacter jejuni
69. Isolation and identification of Campylobacter spp
70. Comparison of different procedures, transport media, and enrichment media for isolation of Campylobacter species from healthy laying hens and humans with diarrhea
71. Typing schemes: Are current methods useful?
72. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors
73. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoro-quinolones in veterinary medicine
74. Vaccines against Campylobacter jejuni
75. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni